
PF-04929113 Mesylate
CAS No. 1173111-67-5
PF-04929113 Mesylate( SNX-5422 Mesylate | PF04929113 Mesylate | SNX5422 Mesylate )
Catalog No. M10581 CAS No. 1173111-67-5
The prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 92 | Get Quote |
![]() ![]() |
5MG | 146 | Get Quote |
![]() ![]() |
10MG | 273 | Get Quote |
![]() ![]() |
25MG | 396 | Get Quote |
![]() ![]() |
50MG | 583 | Get Quote |
![]() ![]() |
100MG | 833 | Get Quote |
![]() ![]() |
500MG | 1683 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-04929113 Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor.
-
DescriptionThe prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor; inhibits several signaling pathways and induces apoptosis in CRPC LNCaP tumors in vivo.Blood Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsSNX-5422 Mesylate | PF04929113 Mesylate | SNX5422 Mesylate
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP90|HER2
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1173111-67-5
-
Formula Weight617.6377
-
Molecular FormulaC26H34F3N5O7S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C.CS(=O)(=O)O
-
Chemical NameGlycine, trans-4-[[2-(aminocarbonyl)-5-[4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl]phenyl]amino]cyclohexyl ester, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lamoureux F, et al. Clin Cancer Res. 2011 Jul 15;17(14):4916.
2. Rajan A, et al. Clin Cancer Res. 2011 Nov 1;17(21):6831-9.
molnova catalog



related products
-
Hexamethylene amilor...
HMA is an amiloride derivative, shown to inhibit TRPA1-mediated calcium signal (IC50: 35 μM). It is an inhibitor of the Na+/H+ exchanger (NHE), with Ki of 0.013-2.4 μM for various NHE isoforms.
-
SNX-0723
SNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM.
-
AMP-PCP disodium
AMP-PCP disodium, an ATP analogue, binds to the N-terminal domain of Hsp90 with a Kd value of 3.8 μM, facilitating the formation of an active Hsp90 homodimer.